| | | | | | | |
 | CSL LIMITED | -1.51% | 1.39% | 1.36% | 0.38% | 29.58% | 100 157 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.80% | -4.62% | -3.88% | -12.59% | 201.91% | 46 957 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -4.88% | -0.35% | -26.31% | -39.43% | 156.07% | 38 992 |
 | BIOGEN INC. | -0.84% | -0.86% | -10.59% | -36.65% | -8.99% | 31 394 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | 0.34% | -4.12% | -25.26% | -38.38% | 91.13% | 21 880 |
| BIOMARIN PHARMACEUTICAL INC. | 0.11% | -2.22% | 5.33% | 24.46% | 20.22% | 17 242 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | 0.29% | -2.02% | -12.86% | -22.85% | --.--% | 17 216 |
 | UCB | 1.05% | -1.39% | -26.88% | -26.10% | 6.38% | 13 984 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -0.56% | -4.22% | -9.85% | -31.03% | --.--% | 9 982 |
| WALVAX BIOTECHNOLOGY CO., LTD. | 6.04% | 2.62% | -20.60% | -42.74% | 59.36% | 9 931 |
| CELLTRION HEALTHCARE CO., LTD. | -0.93% | -3.99% | -7.11% | -35.33% | 96.35% | 8 800 |
 | GRIFOLS, S.A. | -0.71% | -3.79% | -21.66% | -38.17% | -54.32% | 7 884 |
| APELLIS PHARMACEUTICALS, INC. | -0.20% | 0.06% | 38.26% | 8.46% | 126.19% | 7 196 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | -1.67% | 3.77% | -44.05% | -27.57% | 7.10% | 7 141 |
| SK BIOSCIENCE CO.,LTD. | -4.51% | -10.04% | -48.22% | -63.71% | --.--% | 7 063 |
| | | | | | | |
| | Durchschnitt | -0.59% | -1.99% | -14.15% | -25.42% | 60.91% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -1.10% | -1.23% | -9.77% | -18.36% | 72.69% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
